Related references
Note: Only part of the references are listed.Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour
Serguei O. Fetissov
NATURE REVIEWS ENDOCRINOLOGY (2017)
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
Ashkan Afshin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Gut microbiota dysbiosis contributes to the development of hypertension
Jing Li et al.
MICROBIOME (2017)
Role of Niacin in Current Clinical Practice: A Systematic Review
Aakash Garg et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Alirocumab: A Review in Hypercholesterolemia
Sarah L. Greig et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2016)
The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca2+ signalling in steatotic hepatocytes
Eunues S. Ali et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Impact of gut microbiota on diabetes mellitus
G. Blandino et al.
DIABETES & METABOLISM (2016)
Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17 Physiological Effects in the Cardiovascular System
Wang Wang et al.
HYPERTENSION (2016)
Current Understanding of Dysbiosis in Disease in Human and Animal Models
Arianna K. DeGruttola et al.
INFLAMMATORY BOWEL DISEASES (2016)
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events A Systematic Review and Meta-analysis
Rohan Khera et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Valery L. Feigin et al.
LANCET NEUROLOGY (2016)
Diet-microbiota interactions as moderators of human metabolism
Justin L. Sonnenburg et al.
NATURE (2016)
The role of the intestinal microbiota in type 1 diabetes mellitus
Mikael Knip et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clinically Relevant Doses of Enalapril Mitigate Multiple Organ Radiation Injury
Eric P. Cohen et al.
RADIATION RESEARCH (2016)
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
Francesco Salvo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
Francesco Salvo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Therapeutic Potential of 5-HT2C Receptor Agonists for Addictive Disorders
Guy A. Higgins et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice
Vishal Singh et al.
CELL METABOLISM (2015)
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
Jingyuan Fu et al.
CIRCULATION RESEARCH (2015)
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation
Mario Romano et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Gut Dysbiosis Is Linked to Hypertension
Tao Yang et al.
HYPERTENSION (2015)
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Andy Menke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Impact of Diet and Lifestyle on Gut Microbiota and Human Health
Michael A. Conlon et al.
NUTRIENTS (2015)
Risk of new-onset diabetes associated with statin use
Robert D. Beckett et al.
SAGE OPEN MEDICINE (2015)
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
L. B. Ramsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Global estimates of diabetes prevalence for 2013 and projections for 2035
L. Guariguata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Metabolic Syndrome
Susan L. Samson et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2014)
Diabetes Mellitus
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
The contributory role of gut microbiota in cardiovascular disease
W. H. Wilson Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study
Florian Beigel et al.
JOURNAL OF CROHNS & COLITIS (2014)
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013
Marie Ng et al.
LANCET (2014)
Dutch Venous Ulcer guideline update
M. Birgitte Maessen-Visch et al.
PHLEBOLOGY (2014)
Gut microbiota and metabolic syndrome
Davide Festi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Metabolic syndrome in young people
Sukran Poyrazoglu et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2014)
The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies
Jana V. van Vliet-Ostaptchouk et al.
BMC ENDOCRINE DISORDERS (2014)
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
Daniel Keene et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection
F. Drissi et al.
NUTRITION & DIABETES (2014)
A Comprehensive Review on Metabolic Syndrome
Jaspinder Kaur
CARDIOLOGY RESEARCH AND PRACTICE (2014)
Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables
D. Vancampfort et al.
PSYCHOLOGICAL MEDICINE (2014)
Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids
Gijs den Besten et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
Davy Vancampfort et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Phentermine/Topiramate for the Treatment of Obesity
Steven M. Smith et al.
ANNALS OF PHARMACOTHERAPY (2013)
Angiotensin II antagonists - an assessment of their acute toxicity
Dagmar Prasa et al.
CLINICAL TOXICOLOGY (2013)
Resolution phase lipid mediators of inflammation: agonists of resolution
Charles N. Serhan et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
The gut microbiota - masters of host development and physiology
Felix Sommer et al.
NATURE REVIEWS MICROBIOLOGY (2013)
The Prevalence of Metabolic Syndrome in Children: A Systematic Review of the Literature
Amanda Friend et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2013)
Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
Robyn H. Guymer et al.
PLOS ONE (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
The Long-Term Stability of the Human Gut Microbiota
Jeremiah J. Faith et al.
SCIENCE (2013)
Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink
Ian J. Douglas et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
The role of gut microbiota in the gut-brain axis: current challenges and perspectives
Xiao Chen et al.
PROTEIN & CELL (2013)
Chronic disease and the link to physical activity
J. Larry Durstine et al.
JOURNAL OF SPORT AND HEALTH SCIENCE (2013)
Glucagonlike Peptide 1-Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus A Population-Based Matched Case-Control Study
Sonal Singh et al.
JAMA INTERNAL MEDICINE (2013)
Metformin in obesity, cancer and aging: addressing controversies
Lev M. Berstein
AGING-US (2012)
Fenofibrate - A Potential Systemic Treatment for Diabetic Retinopathy?
Tien Yin Wong et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Culture-independent methods for studying environmental microorganisms: methods, application, and perspective
Can Su et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2012)
The Impact of the Gut Microbiota on Human Health: An Integrative View
Jose C. Clemente et al.
CELL (2012)
Cell signalling in insulin secretion: the molecular targets of ATP, cAMP and sulfonylurea
S. Seino
DIABETOLOGIA (2012)
A High-Fat Diet Is Associated With Endotoxemia That Originates From the Gut
Swaroop Pendyala et al.
GASTROENTEROLOGY (2012)
Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Diseases Among Hispanic/Latino Individuals of Diverse Backgrounds in the United States
Martha L. Daviglus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom
Sinead M. Langan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Functional interactions between the gut microbiota and host metabolism
Valentina Tremaroli et al.
NATURE (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
David B. Allison et al.
OBESITY (2012)
Anti-Obesity Drugs: A Review about Their Effects and Safety
Jun Goo Kang et al.
DIABETES & METABOLISM JOURNAL (2012)
Microbial degradation of complex carbohydrates in the gut
Harry J. Flint et al.
GUT MICROBES (2012)
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity
Patrice D. Cani et al.
GUT MICROBES (2012)
Metabolic syndrome: definitions and controversies
Eva Kassi et al.
BMC MEDICINE (2011)
Gut Microbiota and the Pathogenesis of Insulin Resistance
Nathalie M. Delzenne et al.
CURRENT DIABETES REPORTS (2011)
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
Kasia J. Lipska et al.
DIABETES CARE (2011)
Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
Yehuda Handelsman
DIABETES CARE (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Succession of microbial consortia in the developing infant gut microbiome
Jeremy E. Koenig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
Javier A. Bravo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Stroke Declines From Third to Fourth Leading Cause of Death in the United States Historical Perspective and Challenges Ahead
Amytis Towfighi et al.
STROKE (2011)
Effects of the gut microbiota on obesity and glucose homeostasis
Thomas Greiner et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Pharmacotherapies for Obesity: Past, Current, and Future Therapies
Lisa L. Ioannides-Demos et al.
JOURNAL OF OBESITY (2011)
Global prevalence and trends of overweight and obesity among preschool children
Mercedes de Onis et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model
Jurgen Scholze et al.
BMC PUBLIC HEALTH (2010)
Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
Michael S. Kostapanos et al.
Current Vascular Pharmacology (2010)
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
The gut microbiota modulates host energy and lipid metabolism in mice
Vidya R. Velagapudi et al.
JOURNAL OF LIPID RESEARCH (2010)
Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients
Kwang Kon Koh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The metabolic syndrome
Robert H. Eckel et al.
LANCET (2010)
EFFECTS OF THE PROBIOTIC BIFIDOBACTERIUM INFANTIS IN THE MATERNAL SEPARATION MODEL OF DEPRESSION
L. Desbonnet et al.
NEUROSCIENCE (2010)
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
W. Philip T. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cardiovascular Disease Risk Factors: Epidemiology and Risk Assessment
Björn Dahlöf
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Fenofibric Acid In Combination Therapy in the Treatment of Mixed Dyslipidemia
Lily P. H. Yang et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2009)
One-year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial
Mathijs C. Bunck et al.
DIABETES CARE (2009)
A core gut microbiome in obese and lean twins
Peter J. Turnbaugh et al.
NATURE (2009)
The gut microbiota shapes intestinal immune responses during health and disease
June L. Round et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Effects of statins on high-density lipoproteins: A potential contribution to cardiovascular benefit
Fergus McTaggart et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Patrice D. Cani et al.
DIABETES (2008)
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy
Vivian A. Fonseca et al.
DIABETES CARE (2008)
Lorcaserin, a novel selective human 5-Hydroxytryptamine2C agonist:: In vitro and in vivo pharmacological characterization
William J. Thomsen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient
Noemie Chanson et al.
CLINICAL KIDNEY JOURNAL (2008)
Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding
Joseph A. Delaney et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Development of the human infant intestinal microbiota
Chana Palmer et al.
PLOS BIOLOGY (2007)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
Safety considerations with gastrointestinally active lipid-lowering drugs
Terry A. Jacobson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Physical activity in prevention and treatment of the metabolic syndrome
Timo A. Lakka et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2007)
Nutritional strategies in the prevention and treatment of metabolic syndrome
Sabrina E. Feldeisen et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2007)
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Fredrik Backhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Microbial ecology - Human gut microbes associated with obesity
Ruth E. Ley et al.
NATURE (2006)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen
Sergio Britto Garcia et al.
CANCER LETTERS (2006)
Angiotensin receptor blockers may increase risk of myocardial infarction: Unraveling the ARB-MI paradox
Martin H. Strauss et al.
CIRCULATION (2006)
Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects
Gary A. Herman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis - The ASTEROID trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Meglitinide analogues:: a review of clinical data focused on recent trials
JF Blicklé
DIABETES & METABOLISM (2006)
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
SM Grundy
NATURE REVIEWS DRUG DISCOVERY (2006)
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
XK Ding et al.
HEPATOLOGY (2006)
How to explain the differences between renin angiotensin system modulators
BI Levy
AMERICAN JOURNAL OF HYPERTENSION (2005)
Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states:: Focus on novel therapeutic strategies
MJ Millan
THERAPIE (2005)
Obesity alters gut microbial ecology
RE Ley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity
BM Smith et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid lowering arm (ASCOT-LLA): A multicentre randomised controlled trial
PS Sever et al.
DRUGS (2004)
The gut microbiota as an environmental factor that regulates fat storage
F Bäckhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
XENical in the prevention of diabetes in obese subjects (XENDOS) study
JS Torgerson et al.
DIABETES CARE (2004)
Targeting the metabolic syndrome with exercise: Evidence from the HERITAGE Family Study
PT Katzmarzyk et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa
S Fiorucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial
BW McCrindle et al.
JOURNAL OF PEDIATRICS (2003)
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
MA Atkinson et al.
LANCET (2001)
Fat intake and food choices during weight reduction with diet, behavioural modification and a lipase inhibitor
K Franson et al.
JOURNAL OF INTERNAL MEDICINE (2000)
Share Paper
